Hunter Syndrome Therapeutics - Pipeline Assessment

and Market Forecasts to 2019

On 9thDecember 2014

Summary
The industry analysis specialist, has released its new report, Hunter Syndrome Therapeutics Pipeline Assessment and Market Forecasts to 2019. The report is an essential source of
information and analysis on the global Hunter Syndrome Therapeutics market. The report
identifies the key trends shaping and driving the global Hunter Syndrome Therapeutics market.
The report also provides insights on the prevalent competitive landscape and the emerging
players expected to significantly alter the market positioning of the current market leaders.
Most importantly, the report provides valuable insights on the pipeline products within the
global Hunter Syndrome Therapeutics sector. This report is built using data and information
sourced from proprietary databases, primary and secondary research and in-house analysis by
GlobalDatas team of industry experts.

You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-hunter-syndrome-therapeutics-pipeline-assessment-and-marketforecasts-135221

Scope
The report provides information on the key drivers and challenges of the Hunter Syndrome
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Therapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Hunter
Syndrome Therapeutics market revenues data from 2006 to 2011, forecast for eight years to
2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being
developed and emerging trends by seven key markets. Pipeline candidates fall under major
therapeutic classes.
- Analysis of the current and future competition in the seven key countries Hunter Syndrome
Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is
independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet
needs and the implications for the Hunter Syndrome Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Hunter Syndrome Therapeutics
market

Reasons to buy
The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline
products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global
Hunter Syndrome Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies,
market segments and companies likely to impact the global Hunter Syndrome Therapeutics
market in future.
- Formulate effective sales and marketing strategies by understanding the competitive
landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective
counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments
that present maximum opportunities for consolidations, investments and strategic
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

partnerships.
- Whats the next big thing in the global Hunter Syndrome Therapeutics market landscape?
Identify, understand and capitalize.

Other industries we cover:

Advertising and Media

Automotive and Parts
Consumer Goods
Healthcare and Medical
Finance and Banking
Food and Beverages
Travel and Tourism
Textiles and Clothing
SWOT Analysis

Discounts on Market Research Reports till 31st December, 2014

For more inquiries, contact at +91 - 998 729 5242 /
contact@jsbmarketresearch.com

Table of Content
2 Hunter Syndrome Therapeutics - Introduction
2.1 Disease Overview
2.2 Epidemiology
2.2.1 Mortality
2.2.2 Race
2.2.3 Sex
2.2.4 Age
2.2.5 Quality of Life
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

2.3 Etiology and Pathophysiology

2.3.1 Neurological Involvement in the Hunter Syndrome
2.4 Signs and Symptoms
2.5 Diagnosis
2.5.1 Urine Glycosaminoglycans Excretion
2.5.2 Enzyme Activity
2.5.3 Gene Analysis
2.5.4 Prenatal Diagnosis
2.5.5 Diagnostic Algorithm for Hunter Syndrome
2.6 Treatment and Management Pattern
2.6.1 Disease-Specific Approaches to Manage Hunter Syndrome
2.6.2 Non-Disease-Specific Approaches to Manage Hunter Syndrome
2.7 Global Data Pipeline Report Guidance
3 Hunter Syndrome Therapeutics - Market Characterization
3.1 Hunter Syndrome Therapeutics Market Size (2006-2011) - Global
3.2 Hunter Syndrome Therapeutics Market Size (2011-2019) - Global
3.3 Hunter Syndrome Therapeutics Market Size (2006-2011) - The US
3.4 Hunter Syndrome Therapeutics Market Forecast (2011-2019) - The US
3.5 Hunter Syndrome Therapeutics Market Size (2006-2011) - France
3.6 Hunter Syndrome Therapeutics Market Forecast (2011-2019) - France
3.7 Hunter Syndrome Therapeutics Market Size (2006-2011) - Germany
3.8 Hunter Syndrome Therapeutics Market Forecast (2011-2019) - Germany
3.9 Hunter Syndrome Therapeutics Market Size (2006-2011) - Italy
3.10 Hunter Syndrome Therapeutics Market Forecast (2011-2019) - Italy
3.11 Hunter Syndrome Therapeutics Market Size (2006-2011) - Spain
3.12 Hunter Syndrome Therapeutics Market Forecast (2011-2019) - Spain
3.13 Hunter Syndrome Therapeutics Market Size (2006-2011) - The UK
3.14 Hunter Syndrome Therapeutics Market Forecast (2011-2019) - The UK
3.15 Hunter Syndrome Therapeutics Market Size (2006-2011) - Japan
3.16 Hunter Syndrome Therapeutics Market Forecast (2011-2019) - Japan
3.17 Drivers and Barriers for the Hunter Syndrome Therapeutics Market
3.17.1 Drivers for the Hunter Syndrome Therapeutics Market
3.17.2 Barriers for the Hunter Syndrome Therapeutics Market
3.17.3 Opportunity and Unmet Need Analysis
3.18 Key Takeaway
4 Hunter Syndrome Therapeutics - Competitive Assessment
4.1 Overview
4.2 Strategic Competitor Assessment
4.3 Product Profiles for the Major Marketed Products in the Hunter Syndrome Therapeutics
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Market
4.3.1 Elaprase (Idursulfase)
5 Hunter Syndrome Therapeutics - Pipeline Assessment
5.1 Overview
5.2 Strategic Pipeline Assessment
5.3 Hunter Syndrome Therapeutics - Pipeline by Phases of Development
5.3.1 Hunter Syndrome Therapeutics - Phase II Pipeline
5.3.2 Hunter Syndrome Therapeutics - Phase 0 Pipeline
5.3.3 Hunter Syndrome Therapeutics - Preclinical Pipeline
5.4 Hunter Syndrome Therapeutics - Pipeline by Mechanism of Action
5.5 Technology Trends Analytical Framework
5.6 Hunter Syndrome Therapeutics - Promising Drugs under Development
5.7 Molecule Profile for Promising Drugs under Clinical Development
5.7.1 HGT-2310
5.8 Key Takeaway
6 Hunter Syndrome Therapeutics - Clinical Trial Mapping
6.1 Clinical Trial Mapping Overview
6.2 Clinical Trials by Region/Country (US, EU5 and Japan)
6.3 Clinical Trials by Phase
6.4 Clinical Trials by Trial Status
6.5 Prominent Sponsors
6.6 Key Companies Participating in Therapeutics Clinical Trials
7 Hunter Syndrome Therapeutics Market - Strategic Assessment
7.1 Key Events Impacting on the Future Market
7.2 Hunter Syndrome Therapeutics: Implications for Future Market Competition
8 Hunter Syndrome Therapeutics - Future Players
8.1 Introduction
8.2 Company Profiles
8.2.1 Shire
9 Hunter Syndrome Therapeutics - Licensing and Partnership Deals
10 Hunter Syndrome Therapeutics - Appendix
10.1 Market Definitions
10.2 Abbreviations
10.3 Methodology
10.3.1 Coverage
10.3.2 Secondary Research
10.3.3 Forecasting
10.3.4 Primary Research
10.3.5 Expert Panel Validation
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

10.4 Contact Us
10.5 Disclaimer
10.6 Bibliography

List Of Tables
Table 1: MPS Classification
Table 2: Types of Hunter Syndrome (MPS II)
Table 3: Prevalence and Incidence of Hunter Syndrome
Table 4: Signs and Symptoms (Depending upon Organ/System Involved)
Table 5: Urinary Glycosaminoglycans Composition in the MPS
Table 6: Multidisciplinary Treatment and Management of Hunter Syndrome
Table 7: Hunter Syndrome Therapeutics Market, Global, Revenue ($m), 2006-2011
Table 8: Hunter Syndrome Therapeutics Market, Global, Forecast ($m), 2011-2019
Table 9: Hunter Syndrome Therapeutics Market, the US, Revenue ($m), 2006-2011
Table 10: Hunter Syndrome Therapeutics Market, the US, Forecast ($m), 2011-2019
Table 11: Hunter Syndrome Therapeutics Market, France, Forecast ($m), 2006-2011
Table 12: Hunter Syndrome Therapeutics Market, France, Forecast ($m), 2011-2019
Table 13: Hunter Syndrome Therapeutics Market, Germany, Revenue ($m), 2006-2011
Table 14: Hunter Syndrome Therapeutics Market, Germany, Forecast ($m), 2011-2019
Table 15: Hunter Syndrome Therapeutics Market, Italy, Revenue ($m), 2006-2011
Table 16: Hunter Syndrome Therapeutics Market, Italy, Forecast ($m), 2011-2019
Table 17: Hunter Syndrome Therapeutics Market, Spain, Revenue ($m), 2006-2011
Table 18: Hunter Syndrome Therapeutics Market, Spain, Forecast ($m), 2011-2019
Table 19: Hunter Syndrome Therapeutics Market, the UK, Revenue ($m), 2006-2011
Table 20: Hunter Syndrome Therapeutics Market, the UK, Forecast ($m), 2011-2019
Table 21: Hunter Syndrome Therapeutics Market, Japan, Revenue ($m), 2006-2011
Table 22: Hunter Syndrome Therapeutics Market, Japan, Forecast ($m), 2011-2019
Table 23: Clinical Trial of Elaprase
Table 24: Hunter Syndrome Therapeutics - Phase II Pipeline
Table 25: Hunter Syndrome Therapeutics - Phase 0 Pipeline
Table 26: Hunter Syndrome Therapeutics - Preclinical Pipeline
Table 27: Hunter Syndrome Therapeutics- Most Promising Drugs Under Development, 2011
Table 28: Hunter Syndrome Therapeutics - Clinical Trials by Region, 2011
Table 29: Hunter Syndrome Therapeutics, Global, Clinical Trials by Phase of Development, 2011
Table 30: Hunter Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2011
Table 31: Hunter Syndrome Therapeutics Market, Global, Clinical Trials by Overall Sponsors,
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

2011
Table 32: Hunter Syndrome Therapeutics, Global, Clinical Trials by prominent Sponsors, 2011
Table 33: Hunter Syndrome Therapeutics, Global, Key Companies Participating Clinical Trials,
2011
Table 34: Shire - Genetic Disorder Pipeline Portfolio, 2011

List Of Figures
Figure 1: X-Linked Recessive Inheritance
Figure 2: Signs and Symptoms of Hunter Syndrome
Figure 3: Diagnostic Algorithm for Hunter Syndrome
Figure 4: Hunter Syndrome Therapeutics Market, Global, Revenue ($m), 2006-2011
Figure 5: Hunter Syndrome Therapeutics Market, Global, Forecast ($m), 2011-2019
Figure 6: Hunter Syndrome Therapeutics Market, the US, Revenue ($m), 2006-2011
Figure 7: Hunter Syndrome Therapeutics Market, the US, Forecast ($m), 2011-2019
Figure 8: Hunter Syndrome Therapeutics Market, France, Revenue ($m), 2006-2011
Figure 9: Hunter Syndrome Therapeutics Market, France, Forecast ($m), 2011-2019
Figure 10: Hunter Syndrome Therapeutics Market, Germany, Revenue ($m), 2006-2011
Figure 11: Hunter Syndrome Therapeutics Market, Germany, Forecast ($m), 2011-2019
Figure 12: Hunter Syndrome Therapeutics Market, Italy, Revenue ($m), 2006-2011
Figure 13: Hunter Syndrome Therapeutics Market, Italy, Forecast ($m), 2011-2019
Figure 14: Hunter Syndrome Therapeutics Market, Spain, Revenue ($m), 2006-2011
Figure 15: Hunter Syndrome Therapeutics Market, Spain, Forecast ($m), 2011-2019
Figure 16: Hunter Syndrome Therapeutics Market, the UK, Revenue ($m), 2006-2011
Figure 17: Hunter Syndrome Therapeutics Market, the UK, Forecast ($m), 2011-2019
Figure 18: Hunter Syndrome Therapeutics Market, Japan, Revenue ($m), 2006-2011
Figure 19: Hunter Syndrome Therapeutics Market, Japan, Forecast ($m), 2011-2019
Figure 20: Opportunity and Unmet Need in the Hunter Syndrome Therapeutics Market, 2011
Figure 21: Strategic Competitor Assessment for Hunter Syndrome, 2011
Figure 22: Hunter Syndrome Therapeutics Pipeline by Phase of Development, 2011
Figure 23: Hunter Syndrome Therapeutics - Pipeline by Mechanism of Action, 2011
Figure 24: Technology Trends Analytic Framework of the Hunter Syndrome Therapeutics
Pipeline, 2011
Figure 25: Technology Trends Analytic Framework of the Hunter Syndrome Therapeutics
Pipeline, 2011
Figure 26: Hunter Syndrome Therapeutics - Clinical Trials by Region, 2011
Figure 27: Hunter Syndrome Therapeutics, Global, Clinical Trials by Phase of Development, 2011
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Figure 28: Hunter Syndrome Therapeutics, Global, Clinical Trials by Overall Sponsors, 2011
Figure 29: Hunter Syndrome Therapeutics, Global, Clinical Trials by Prominent Sponsors, 2011
Figure 30: Hunter Syndrome Therapeutics, Global, Key Companies Participating Clinical Trials,
2011
Figure 31: Hunter Syndrome Therapeutics Market, Drivers and Barriers, 2011
Figure 32: Implications for Future Market Competition in the Hunter Syndrome Therapeutics
Market, 2011

Report Price:
Licence Type

Price

PDF

$ 3995

Site Licence

$ 7990

Enterprise Wide Licence

$ 11985

Related Reports:
Traumatic Brain Injury Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Osteoarthritis (OA) Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Posttraumatic Stress Disorder Therapeutics (PTSD) - Pipeline Assessment and Market Forecasts to
2019
Leiomyosarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Waldenstrms Macroglobulinemia Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Gastrointestinal Stromal Tumors (GIST) Therapeutics - Pipeline Assessment and Market Forecasts to
2019
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Retinoblastoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Xerostomia Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Cytomegalovirus (CMV) Infections - Pipeline Assessment and Market Forecasts to 2019

You can order this report by calling on +91 - 998 7295 242 or mail us
your contact details at contact@jsbmarketresearch.com

About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along
with providing in-depth analysis though reports, JSB market research also provides regular
updates of the market though newsletters. Our reports are a well-researched work of market
researchers with an extensive knowledge and a good level of market experience.

To know more on Hunter Syndrome Therapeutics - Pipeline Assessment and

Market Forecasts to 2019
http://www.jsbmarketresearch.com/healthcare-medical/r-hunter-syndrometherapeutics-pipeline-assessment-and-market-forecasts-135221

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/